Director, Formulation and Stabilization Sciences, Vaccine Production Program
National Institutes of Health (NIH)
Dr. Kueltzo is currently the Director of the Formulation and Stabilization Sciences program at the Vaccine Production Program within the National Institutes for Allergy and Infectious Disease at the NIH. The program profile includes Phase I/II formulation of glycosylated trimers, virus-like particle, ferritin-nanoparticle based vaccine candidates as well as high concentration monoclonal antibodies for prophylactic and therapeutic applications.
Dr. Kueltzo received her B.S. in Pharmacy from Purdue University. She obtained her Ph.D. in Pharmaceutical Chemistry at University of Kansas in 2002, under Dr. C. Russell Middaugh, followed by post-doctoral experience under Dr. John Carpenter in the Department of Pharmaceutical Sciences, University of Colorado between 2002 and 2005. Her work focused on biophysical characterization, stabilization and process instability of multiple therapeutic proteins and monoclonal antibodies. Following her post-doctoral studies, Dr. Kueltzo led the analytical development efforts at GlobeImmune, Inc. in Louisville, Colorado, focusing on immunotherapy approaches to treatment of cancer and infectious disease targets, prior to joining the National Institutes of Health in 2011.